What we do
The Simcyp Population-based ADME Simulator
Simcyp provides a platform for modelling and simulation of drug absorption, distribution, metabolism and excretion (ADME) in virtual populations. The Simulator is licensed to our Consortium member clients for use in drug discovery and development.
Currently, 9 of the top 10 pharmaceutical companies worldwide have access to Simcyp expertise through Consortium membership. The Consortium helps guide scientific development at Simcyp, ensuring that our products continue to meet, and exceed, industry needs.
Simcyp maintains strong academic links and our science team conducts internationally recognised cutting-edge research and development. We also offer consultancy services and run education programmes around the world.
